Machine Learning Model to Predict Outcome in Acute Hypoxemic Respiratory Failure
MEMORIAL
Developing an Optimal Machine Learning Model to Predict ICU Outcome in Patients With Acute Hypoxemic Respiratory Failure
1 other identifier
observational
1,241
1 country
8
Brief Summary
Acute hypoxemic respiratory failure (AHRF) is the most common cause of admission in the intensive care units (UCIs) worldwide. We will assess the value of machine learning (ML) techniques for early prediction of ICU death in 1,241 patients enrolled in the PANDORA (Prevalence AND Outcome of acute Respiratory fAilure) Study in Spain. The study was registered with ClinicalTrials.gov (NCT03145974). Our aim is to evaluate the minimum number of variables models using logistic regression and four supervised ML algorithms: Random Forest, Extreme Gradient Boosting, Support Vector Machine and Multilayer Perceptron.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Mar 2024
Typical duration for all trials
8 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
March 19, 2024
CompletedStudy Start
First participant enrolled
March 19, 2024
CompletedFirst Posted
Study publicly available on registry
March 27, 2024
CompletedPrimary Completion
Last participant's last visit for primary outcome
May 30, 2026
ExpectedStudy Completion
Last participant's last visit for all outcomes
May 30, 2026
February 11, 2025
February 1, 2025
2.2 years
March 19, 2024
February 7, 2025
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
ICU mortality
death in the intensive care unit
up to 100 weeks (from inclusion to death or diascharge from intensive care unit
Secondary Outcomes (1)
MV duration
up to 100 weeks (from inclusion to extubation)
Study Arms (3)
Derivation cohort
It will contain 800 patients randomly selected (1,000 patients with AHRF)
Validation cohort
It will contain 200 patients randomly selected (20% of 1000 patients with AHRF
Confirmatory cohort
It will contain the remaining 241 patients randomply selected (por external validation)
Interventions
We will use robust machine learning approaches, such as Random Forest, Extreme Gradient Boosting, Support Vector Machine and Multilayer Perceptron.
Eligibility Criteria
De-identified dataset inclusing 1,241 mechanically ventilated patients with acute hypoxemic respiratory failure admitted consecutively in a network of Spanish ICUs.
You may qualify if:
- endotracheal intubation plus mechanical ventilation (MV)
- PaO2/FiO2 ratio ≤300 mmHg under MV with positive end-expiratory pressure (PEEP) ≥5 cmH2O and FiO2 ≥0.3.
You may not qualify if:
- Post-operative patients ventilated \<24 h
- Brain death patients.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (8)
Hospital General Universitario de Ciudad Real
Ciudad Real, 13005, Spain
Hospital Virgen de La Luz
Cuenca, 16002, Spain
Hospital Universitario La Paz
Madrid, 28046, Spain
Hospital Universitario Puerta de Hierro
Madrid, 28222, Spain
Hospital Universitario Virgen de Arrixaca
Murcia, 3012, Spain
Hospital Universitario NS de Candelaria
Santa Cruz de Tenerife, 38010, Spain
Hospital Cinico de Valencia
Valencia, 46010, Spain
Hospital Universitario Rio Hortega
Valladolid, 47012, Spain
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Jesus Villar, MD, PhD
Fundación Canaria Instituto de Investigación Sanitaria de Canarias
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- principal investigator
Study Record Dates
First Submitted
March 19, 2024
First Posted
March 27, 2024
Study Start
March 19, 2024
Primary Completion (Estimated)
May 30, 2026
Study Completion (Estimated)
May 30, 2026
Last Updated
February 11, 2025
Record last verified: 2025-02
Data Sharing
- IPD Sharing
- Will not share